James F. Holland | |
|---|---|
.jpg) James F. Holland | |
| Born | May 16, 1925 Morristown, New Jersey, U.S. |
| Died | March 22, 2018 (aged 92) Scarsdale, New York, U.S. |
| Education | Columbia University College of Physicians and Surgeons |
| Medical career | |
| Profession | Physician |
| Institutions | National Cancer Institute, Roswell Park Comprehensive Cancer Center, Icahn School of Medicine at Mount Sinai |
| Sub-specialties | Oncology |
| Research | Combination chemotherapy |
| Awards | Lasker Award, 1972 |
James Frederick Holland (May 16, 1925 – March 22, 2018) was an American physician and Distinguished Professor of Neoplastic Diseases at the Icahn School of Medicine at Mount Sinai in New York. Early in his career, he had worked for the National Cancer Institute and Roswell Park Comprehensive Cancer Center.
Holland was considered a key figure in the development of cancer chemotherapy. His 1953 clinical trial on acute leukemia resulted in the formation of Acute Leukemia Group B, a research collaboration that later became known as the Cancer and Leukemia Group B. He served as president of the American Society of Clinical Oncology and the American Association for Cancer Research.